Publications by authors named "Hideki Tsujimura"

Claim this Profile
E
Efficacy of polatuzumab vedotin versus conventional chemotherapy in relapsed or refractory diffuse large B-cell lymphoma.
Tatsuzo Mishina, Chika Manako, Takeaki Sugawara, Hideki Tsujimura, Kyoya Kumagai

Int J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipidomic profiling of plasma from patients with multiple myeloma receiving bortezomib: an exploratory biomarker study of JCOG1105 (JCOG1105A1).
Masaki Ri, Shinsuke Iida, Kosuke Saito, Yoshiro Saito, Dai Maruyama, Hideki Tsujimura

Cancer Chemother Pharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.
Kazuyuki Shimada, Ken Ohmachi, Ryunosuke Machida, Shuichi Ota, Hidekazu Itamura, Hideki Tsujimura

Ann Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-hit follicular lymphoma diagnosed due to central nervous system symptoms.
Chika Kawajiri-Manako, Tatsuzo Mishina, Hideki Tsujimura, Satoshi Maruyama, Akiyasu Sato

Ann Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma.
Satsuki Murakami, Masaki Ri, Masato Ito, Nobuhiko Nakamura, Senji Kasahara, Hideki Tsujimura

Int J Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
Dai Maruyama, Shinsuke Iida, Ryunosuke Machida, Shigeru Kusumoto, Noriko Fukuhara, Hideki Tsujimura

Cancer Sci· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synchronous early-stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report.
Ryotaro Eto, Rikiya Nakamura, Naohito Yamamoto, Toshiko Miyaki, Shoko Hayama, Hideki Tsujimura

Mol Clin Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B-cell lymphoma in a Japanese cohort.
Tatsuzo Mishina, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Masaki Fukuyo, Hajime Kageyama, Hideki Tsujimura

Br J Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1).
Masaki Ri, Shinsuke Iida, Dai Maruyama, Aya Sakabe, Ryo Kamei, Hideki Tsujimura

Cancer Sci· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy.
Nobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, Yoshiko Atsuta, Rika Sakai, Hideki Tsujimura

Cancer Sci· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
Dai Maruyama, Shinsuke Iida, Gakuto Ogawa, Noriko Fukuhara, Sachiko Seo, Hideki Tsujimura

Br J Haematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidation with Yttrium-ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.
Katsuhiro Miura, Hideki Tsujimura, Yasufumi Masaki, Masaki Iino, Jun Takizawa

Hematol Oncol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study.
Yoshitoyo Kagami, Kazuhito Yamamoto, Taro Shibata, Kensei Tobinai, Yoshitaka Imaizumi, Hideki Tsujimura

Cancer Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ultra-high sensitivity HBsAg assay can diagnose HBV reactivation following rituximab-based therapy in patients with lymphoma.
Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, Takashi Watanabe, Masanobu Nakata, Hideki Tsujimura

J Hepatol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with brentuximab vedotin in patients with relapsed/refractory classical Hodgkin lymphoma or systemic anaplastic large-cell lymphoma: a multicenter retrospective study.
Noriko Fukuhara, Go Yamamoto, Hideki Tsujimura, Takaaki Chou, Hirohiko Shibayama

Leuk Lymphoma· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14).
Kuniaki Itoh, Tadahiko Igarashi, Hiroyuki Irisawa, Nobuyuki Aotsuka, Shinichi Masuda, Hideki Tsujimura

Leuk Lymphoma· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm].
Keiko Ono, Mikiko Ise, Dai Ikebe, Akiyasu Sato, Xiaofei Wang, Hideki Tsujimura

Rinsho Ketsueki· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Host-Dependent Prognostic Model for Elderly Patients with Diffuse Large B-Cell Lymphoma.
Katsuhiro Miura, Jun Konishi, Takaaki Miyake, Masanori Makita, Atsuko Hojo, Hideki Tsujimura

Oncologist· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of CD38 Expression in Relapsed Refractory Multiple Myeloma.
Mikiko Ise, Keiko Matsubayashi, Hideki Tsujimura, Kyoya Kumagai

Clin Lymphoma Myeloma Leuk· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Primary gastrointestinal follicular lymphoma of the small intestine with massive hemorrhage: a report of three cases].
Akiyasu Sato, Hideki Tsujimura, Takahiro Sugiyama, Satoshi Maruyama, Shuhei Yamada

Rinsho Ketsueki· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy.
Kiyoko Kawamura, Akihiko Wada, Ji-Yang Wang, Quanhai Li, Akihiro Ishii, Hideki Tsujimura

J Cancer Res Clin Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maxillary Swelling as the First Evidence of Multiple Myeloma.
Atsushi Kasamatsu, Yasushi Kimura, Hideki Tsujimura, Harusachi Kanazawa, Nao Koide

Case Rep Dent· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
Shigeru Kusumoto, Yasuhito Tanaka, Ritsuro Suzuki, Takashi Watanabe, Masanobu Nakata, Hideki Tsujimura

Clin Infect Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Administration Order of FEC-DOC in Breast Cancer Adjuvant Chemotherapy Has an Effect on Toxicity].
Toshiko Miyaki, Hideki Tsujimura, Rikiya Nakamura, Yoshiyuki Okubo, Kyoya Kumagai

Gan To Kagaku Ryoho· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention and management of appetite loss during cancer chemotherapy].
Hideki Tsujimura, Mitsugi Yamada, Eri Asako, Yukako Kodama, Tsuneo Sato

Gan To Kagaku Ryoho· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis